Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-12 · accession 0001209191-22-060939 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-13 | 2022-12-12 | XENE | AZAB MOHAMMAD | Dir | M - OptEx | $2.68 | +3,086 | 69.9K | +5% | +$8,270 |
| D | 2022-12-13 | 2022-12-12 | XENE | AZAB MOHAMMAD | Dir | M - OptEx | $0.00 | -3,086 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-12 | M | A | 3,086 | $2.68 | 69,905 | D | — | — | (F1) The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-12-12 | M | D | 3,086 | $0.00 | 0 | D | $2.68 · — to 2022-12-31 | 3,086 Common Shares | (F1) The exercise price was converted to U.S. dollars from $2.67 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. (F2) The shares subject to the option are fully vested and exercisable. |